Innovative Molecular and Cellular Therapeutics in Cleft Palate Tissue Engineering
Tissue Engineering Part B: Reviews
First page number:
Last page number:
Clefts of the lip and/or palate are the most prevalent orofacial birth defects occurring in about 1:700 live human births worldwide. Early postnatal surgical interventions are extensive and staged to bring about optimal growth and fusion of palatal shelves. Severe cleft defects pose a challenge to correct with surgery alone, resulting in complications and sequelae requiring life-long, multidisciplinary care. Advances made in materials science innovation, including scaffold-based delivery systems for precision tissue engineering, now offer new avenues for stimulating bone formation at the site of surgical correction for palatal clefts. In this study, we review the present scientific literature on key developmental events that can go awry in palate development and the common surgical practices and challenges faced in correcting cleft defects. How key osteoinductive pathways implicated in palatogenesis inform the design and optimization of constructs for cleft palate correction is discussed within the context of translation to humans. Finally, we highlight new osteogenic agents and innovative delivery systems with the potential to be adopted in engineering-based therapeutic approaches for the correction of palatal defects.
Cleft palate; Tissue engineering; Drug delivery; Regenerative surgery; Craniofacial; Polymer scaffold
Biomedical Engineering and Bioengineering | Oral and Maxillofacial Surgery
Oliver, J. D.,
Halpern, L. R.,
Graham, E. M.,
Turner, E. C.,
Colombo, J. S.,
Grainger, D. W.,
D'Souza, R. N.
Innovative Molecular and Cellular Therapeutics in Cleft Palate Tissue Engineering.
Tissue Engineering Part B: Reviews, 27(3),